IBDEI0DE ; ; 01-MAY-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 01, 2020
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,982,0)
 ;;=ORTHOTIC DEVICES^13^75
 ;;^UTILITY(U,$J,358.4,983,0)
 ;;=KINESIOTHERAPY^11^75
 ;;^UTILITY(U,$J,358.4,984,0)
 ;;=THERAPY EVALUATIONS^18^75
 ;;^UTILITY(U,$J,358.4,985,0)
 ;;=WOUND CARE^20^75
 ;;^UTILITY(U,$J,358.4,986,0)
 ;;=CARDIAC REHAB^4^75
 ;;^UTILITY(U,$J,358.4,987,0)
 ;;=EDUCATION/TRAINING^7^75
 ;;^UTILITY(U,$J,358.4,988,0)
 ;;=HOME THERAPY SERVICES^9^75
 ;;^UTILITY(U,$J,358.4,989,0)
 ;;=NEUROMUSCULAR TESTING^12^75
 ;;^UTILITY(U,$J,358.4,990,0)
 ;;=TEAM CONFERENCE^16^75
 ;;^UTILITY(U,$J,358.4,991,0)
 ;;=HEALTH BEHAVIORS^8^75
 ;;^UTILITY(U,$J,358.4,992,0)
 ;;=RECREATION THERAPY^14^75
 ;;^UTILITY(U,$J,358.4,993,0)
 ;;=DEVICES/SUPPLIES^5^75
 ;;^UTILITY(U,$J,358.4,994,0)
 ;;=TENS^17^75
 ;;^UTILITY(U,$J,358.4,995,0)
 ;;=ACUPUNCTURE^1^75
 ;;^UTILITY(U,$J,358.4,996,0)
 ;;=INJECTIONS^10^75
 ;;^UTILITY(U,$J,358.4,997,0)
 ;;=SPINAL CORD STIMULATOR^15^75
 ;;^UTILITY(U,$J,358.4,998,0)
 ;;=ADAPTIVE BEHAVIOR ASSESSMENTS^2^75
 ;;^UTILITY(U,$J,358.4,999,0)
 ;;=ADAPTIVE BEHAVIOR TREATMENT^3^75
 ;;^UTILITY(U,$J,358.4,1000,0)
 ;;=AMPUTATION STATUS^1^76
 ;;^UTILITY(U,$J,358.4,1001,0)
 ;;=BRAIN DISORDERS^2^76
 ;;^UTILITY(U,$J,358.4,1002,0)
 ;;=CARDIOPULMONARY^4^76
 ;;^UTILITY(U,$J,358.4,1003,0)
 ;;=COMPLICATIONS DUE TO^5^76
 ;;^UTILITY(U,$J,358.4,1004,0)
 ;;=MUSCULOSKELETAL/CONNECTIVE TISSUE^12^76
 ;;^UTILITY(U,$J,358.4,1005,0)
 ;;=Z CODES^21^76
 ;;^UTILITY(U,$J,358.4,1006,0)
 ;;=BRAIN INJURY - TRAUMATIC^3^76
 ;;^UTILITY(U,$J,358.4,1007,0)
 ;;=FEMUR/THIGH/KNEE FRACTURE^7^76
 ;;^UTILITY(U,$J,358.4,1008,0)
 ;;=FOOT/TOE/ANKLE FRANCTURE^8^76
 ;;^UTILITY(U,$J,358.4,1009,0)
 ;;=HAND/FINGER FRACTURE^9^76
 ;;^UTILITY(U,$J,358.4,1010,0)
 ;;=HIP/PELVIS FRACTURE^10^76
 ;;^UTILITY(U,$J,358.4,1011,0)
 ;;=HUMERUS/SHOULDER FRACTURE^11^76
 ;;^UTILITY(U,$J,358.4,1012,0)
 ;;=TIBIA/FIBULA FRACTURE^19^76
 ;;^UTILITY(U,$J,358.4,1013,0)
 ;;=SPINE FRACTURE^16^76
 ;;^UTILITY(U,$J,358.4,1014,0)
 ;;=WRIST/FOREARM FRACTURE^20^76
 ;;^UTILITY(U,$J,358.4,1015,0)
 ;;=OTHER FRACTURE^14^76
 ;;^UTILITY(U,$J,358.4,1016,0)
 ;;=PAIN^15^76
 ;;^UTILITY(U,$J,358.4,1017,0)
 ;;=SPINAL CONDITIONS^17^76
 ;;^UTILITY(U,$J,358.4,1018,0)
 ;;=SYMPTOMS^18^76
 ;;^UTILITY(U,$J,358.4,1019,0)
 ;;=FALLS^6^76
 ;;^UTILITY(U,$J,358.4,1020,0)
 ;;=NERVES^13^76
 ;;^UTILITY(U,$J,358.4,1021,0)
 ;;=COMMON DIAGNOSES^1^77
 ;;^UTILITY(U,$J,358.4,1022,0)
 ;;=BODY MASS INDEX^3^77
 ;;^UTILITY(U,$J,358.4,1023,0)
 ;;=OBESITY^4^77
 ;;^UTILITY(U,$J,358.4,1024,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^5^77
 ;;^UTILITY(U,$J,358.4,1025,0)
 ;;=ANTICOAGULATION^2^77
 ;;^UTILITY(U,$J,358.4,1026,0)
 ;;=MD/NP/PA ^1^78
 ;;^UTILITY(U,$J,358.4,1027,0)
 ;;=RN/LPN/SW/OTH HC PROF^2^78
 ;;^UTILITY(U,$J,358.4,1028,0)
 ;;=GROUP^3^78
 ;;^UTILITY(U,$J,358.4,1029,0)
 ;;=NEW PATIENT^2^79
 ;;^UTILITY(U,$J,358.4,1030,0)
 ;;=ESTABLISHED PATIENT^1^79
 ;;^UTILITY(U,$J,358.4,1031,0)
 ;;=POST-OP (GLOBAL)^3^79
 ;;^UTILITY(U,$J,358.4,1032,0)
 ;;=JOINT INJECTIONS^15^80
 ;;^UTILITY(U,$J,358.4,1033,0)
 ;;=TENDON INJECTION^26^80
 ;;^UTILITY(U,$J,358.4,1034,0)
 ;;=SKIN PROCEDURES^24^80
 ;;^UTILITY(U,$J,358.4,1035,0)
 ;;=ADMINISTRATION OF INJ MEDICATIONS^2^80
 ;;^UTILITY(U,$J,358.4,1036,0)
 ;;=EKG^10^80
 ;;^UTILITY(U,$J,358.4,1037,0)
 ;;=NOSEBLEEDS^16^80
 ;;^UTILITY(U,$J,358.4,1038,0)
 ;;=REMOVAL FB IN EAR^18^80
 ;;^UTILITY(U,$J,358.4,1039,0)
 ;;=INJECTABLE MEDICATIONS^13^80
 ;;^UTILITY(U,$J,358.4,1040,0)
 ;;=INFUSION MEDICATIONS^11^80
 ;;^UTILITY(U,$J,358.4,1041,0)
 ;;=ADMINISTRATION OF IV MEDICATIONS^3^80
 ;;^UTILITY(U,$J,358.4,1042,0)
 ;;=INHALATION SOLUTIONS THRU DME^12^80
 ;;^UTILITY(U,$J,358.4,1043,0)
 ;;=ADMINISTRATION OF DME^1^80
 ;;^UTILITY(U,$J,358.4,1044,0)
 ;;=DEMO OF METERED INHALER^9^80
 ;;^UTILITY(U,$J,358.4,1045,0)
 ;;=BLOOD TESTS^6^80
 ;;^UTILITY(U,$J,358.4,1046,0)
 ;;=BLADDER ^5^80
 ;;^UTILITY(U,$J,358.4,1047,0)
 ;;=BLOOD TRANSFUSION^7^80
 ;;^UTILITY(U,$J,358.4,1048,0)
 ;;=AIRWAY TREATMENTS^4^80
 ;;^UTILITY(U,$J,358.4,1049,0)
 ;;=BURN TREATMENT^8^80
 ;;^UTILITY(U,$J,358.4,1050,0)
 ;;=TB TEST^25^80
 ;;^UTILITY(U,$J,358.4,1051,0)
 ;;=REPAIR-SIMPLE-SCALP,NK,TRUNK^20^80
 ;;^UTILITY(U,$J,358.4,1052,0)
 ;;=REPAIR-SIMPLE-FACE,MUCOUS^19^80
 ;;^UTILITY(U,$J,358.4,1053,0)
 ;;=REPAIR-INTERM-SCALP,TRUNK^23^80
 ;;^UTILITY(U,$J,358.4,1054,0)
 ;;=REPAIR-INTERM-NK,HAND,FT,GENITALIA^22^80
 ;;^UTILITY(U,$J,358.4,1055,0)
 ;;=REPAIR-INTERM-FACE,MUCOUS^21^80
 ;;^UTILITY(U,$J,358.4,1056,0)
 ;;=OTHER^27^80
 ;;^UTILITY(U,$J,358.4,1057,0)
 ;;=PSYCHIATRY^17^80
 ;;^UTILITY(U,$J,358.4,1058,0)
 ;;=PC COMMON DIAGNOSES^1^81
 ;;^UTILITY(U,$J,358.4,1059,0)
 ;;=ADMINISTRATIVE TOPICS^15^81
 ;;^UTILITY(U,$J,358.4,1060,0)
 ;;=ANGINA^16^81
 ;;^UTILITY(U,$J,358.4,1061,0)
 ;;=ATHEROSCLEROSIS^17^81
 ;;^UTILITY(U,$J,358.4,1062,0)
 ;;=CARDIOVASCULAR^18^81
 ;;^UTILITY(U,$J,358.4,1063,0)
 ;;=DERMATOLOGY^22^81
 ;;^UTILITY(U,$J,358.4,1064,0)
 ;;=EAR DISORDERS^24^81
 ;;^UTILITY(U,$J,358.4,1065,0)
 ;;=EENT^25^81
 ;;^UTILITY(U,$J,358.4,1066,0)
 ;;=ENDOCRINE/METABOLIC^26^81
 ;;^UTILITY(U,$J,358.4,1067,0)
 ;;=EYE DISORDERS^27^81
 ;;^UTILITY(U,$J,358.4,1068,0)
 ;;=EYE INJURY^28^81
 ;;^UTILITY(U,$J,358.4,1069,0)
 ;;=GASTROENTEROLOGY^29^81
 ;;^UTILITY(U,$J,358.4,1070,0)
 ;;=GU/RENAL^30^81
 ;;^UTILITY(U,$J,358.4,1071,0)
 ;;=HEADACHE^31^81
 ;;^UTILITY(U,$J,358.4,1072,0)
 ;;=HEART VALVE DISEASE^32^81
 ;;^UTILITY(U,$J,358.4,1073,0)
 ;;=HEMATOLOGY/ONCOLOGY^33^81
 ;;^UTILITY(U,$J,358.4,1074,0)
 ;;=HISTORY OF ILLNESS^34^81
 ;;^UTILITY(U,$J,358.4,1075,0)
 ;;=INFECTIOUS DISEASE^35^81
 ;;^UTILITY(U,$J,358.4,1076,0)
 ;;=LIVER DISEASE^36^81
 ;;^UTILITY(U,$J,358.4,1077,0)
 ;;=MENTAL HEALTH^38^81
 ;;^UTILITY(U,$J,358.4,1078,0)
 ;;=MOVEMENT DISORDERS^39^81
 ;;^UTILITY(U,$J,358.4,1079,0)
 ;;=MUSCULOSKELETAL^40^81
 ;;^UTILITY(U,$J,358.4,1080,0)
 ;;=NEUROLOGY^41^81
 ;;^UTILITY(U,$J,358.4,1081,0)
 ;;=PAIN^42^81
 ;;^UTILITY(U,$J,358.4,1082,0)
 ;;=PREVENTIVE HEALTH^43^81
 ;;^UTILITY(U,$J,358.4,1083,0)
 ;;=PULMONARY^44^81
 ;;^UTILITY(U,$J,358.4,1084,0)
 ;;=SEXUAL TRAUMA^45^81
 ;;^UTILITY(U,$J,358.4,1085,0)
 ;;=SIGNS,SYMPTOMS,CONDITIONS^46^81
 ;;^UTILITY(U,$J,358.4,1086,0)
 ;;=SPRAIN/STRAIN-INITIAL ENCOUNTER^47^81
 ;;^UTILITY(U,$J,358.4,1087,0)
 ;;=SUBSTANCE DISORDERS^48^81
 ;;^UTILITY(U,$J,358.4,1088,0)
 ;;=VARICOSE VEINS^50^81
 ;;^UTILITY(U,$J,358.4,1089,0)
 ;;=WOMEN'S HEALTH^51^81
 ;;^UTILITY(U,$J,358.4,1090,0)
 ;;=WOUNDS-INITIAL ENCOUNTER^52^81
 ;;^UTILITY(U,$J,358.4,1091,0)
 ;;=COMA^20^81
 ;;^UTILITY(U,$J,358.4,1092,0)
 ;;=CAUSES OF INJURY^19^81
 ;;^UTILITY(U,$J,358.4,1093,0)
 ;;=DEMENTIA^21^81
 ;;^UTILITY(U,$J,358.4,1094,0)
 ;;=LONG TERM CURRENT DRUG THERAPY^37^81
 ;;^UTILITY(U,$J,358.4,1095,0)
 ;;=ACQUIRED ABSENCE OF BODY PART(S)^2^81
 ;;^UTILITY(U,$J,358.4,1096,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^49^81
 ;;^UTILITY(U,$J,358.4,1097,0)
 ;;=ACSC ACUTE KIDNEY FAILURE^3^81
 ;;^UTILITY(U,$J,358.4,1098,0)
 ;;=ACSC ANGINA^4^81
 ;;^UTILITY(U,$J,358.4,1099,0)
 ;;=ACSC ASTHMA/BRONCHITIS/COPD^5^81
 ;;^UTILITY(U,$J,358.4,1100,0)
 ;;=ACSC CHF^6^81
 ;;^UTILITY(U,$J,358.4,1101,0)
 ;;=ACSC DEHYDRATION^7^81
 ;;^UTILITY(U,$J,358.4,1102,0)
 ;;=ACSC DIABETES TYPE 1^8^81
 ;;^UTILITY(U,$J,358.4,1103,0)
 ;;=ACSC DIABETES TYPE 2^9^81
 ;;^UTILITY(U,$J,358.4,1104,0)
 ;;=ACSC HYPERTENSION^10^81
 ;;^UTILITY(U,$J,358.4,1105,0)
 ;;=ACSC INFECTIOUS GASTROENTERITIS^11^81
 ;;^UTILITY(U,$J,358.4,1106,0)
 ;;=ACSC PNEUMONIA^12^81
 ;;^UTILITY(U,$J,358.4,1107,0)
 ;;=ACSC UTI^13^81
 ;;^UTILITY(U,$J,358.4,1108,0)
 ;;=ACSC VIRAL ENTERITIS^14^81
 ;;^UTILITY(U,$J,358.4,1109,0)
 ;;=E-CIG/VAPE LUNG INJURY^23^81
 ;;^UTILITY(U,$J,358.4,1110,0)
 ;;=NEW PATIENT^2^82
 ;;^UTILITY(U,$J,358.4,1111,0)
 ;;=ESTABLISHED PATIENT^1^82
 ;;^UTILITY(U,$J,358.4,1112,0)
 ;;=CONSULTATIONS^3^82
 ;;^UTILITY(U,$J,358.4,1113,0)
 ;;=POST OP VISIT (GLOBAL)^4^82
 ;;^UTILITY(U,$J,358.4,1114,0)
 ;;=PENIS & SCROTUM^7^83
 ;;^UTILITY(U,$J,358.4,1115,0)
 ;;=URINARY TRACT DRAINAGE & IMAGING^10^83
 ;;^UTILITY(U,$J,358.4,1116,0)
 ;;=URODYNAMICS^11^83
 ;;^UTILITY(U,$J,358.4,1117,0)
 ;;=INJ & INTRAVESICAL MEDS^4^83
 ;;^UTILITY(U,$J,358.4,1118,0)
 ;;=CYSTOURETHROSCOPY^1^83
 ;;^UTILITY(U,$J,358.4,1119,0)
 ;;=PROSTATE BIOPSY & IMAGING^8^83
 ;;^UTILITY(U,$J,358.4,1120,0)
 ;;=NURSING PROCEDURES^6^83
 ;;^UTILITY(U,$J,358.4,1121,0)
 ;;=MISCELLANEOUS^5^83
 ;;^UTILITY(U,$J,358.4,1122,0)
 ;;=IMMUNIZATION ADMIN^2^83
 ;;^UTILITY(U,$J,358.4,1123,0)
 ;;=IMMUNIZATIONS^3^83
 ;;^UTILITY(U,$J,358.4,1124,0)
 ;;=TRANSURETHRAL SURGERY^9^83
 ;;^UTILITY(U,$J,358.4,1125,0)
 ;;=BLADDER^4^84
 ;;^UTILITY(U,$J,358.4,1126,0)
 ;;=BENIGN NEOPLASIA-KIDNEY/URETER^2^84
 ;;^UTILITY(U,$J,358.4,1127,0)
 ;;=KIDNEY/URETER^6^84
 ;;^UTILITY(U,$J,358.4,1128,0)
 ;;=MALIGNANT NEOPLASMS^7^84
 ;;^UTILITY(U,$J,358.4,1129,0)
 ;;=COMPLICATIONS^5^84
 ;;^UTILITY(U,$J,358.4,1130,0)
 ;;=NEURO UROLOGY^8^84
 ;;^UTILITY(U,$J,358.4,1131,0)
 ;;=BENIGN NEOPLASM-PENIS^3^84
 ;;^UTILITY(U,$J,358.4,1132,0)
 ;;=SEXUAL DISORDERS^12^84
 ;;^UTILITY(U,$J,358.4,1133,0)
 ;;=PENIS^9^84
 ;;^UTILITY(U,$J,358.4,1134,0)
 ;;=POST OPERATIVE COMPLICATIONS^10^84
 ;;^UTILITY(U,$J,358.4,1135,0)
 ;;=PROSTATIC CONDITIONS^11^84
 ;;^UTILITY(U,$J,358.4,1136,0)
 ;;=TESTICULAR CONDITIONS^14^84
 ;;^UTILITY(U,$J,358.4,1137,0)
 ;;=URETHRA^16^84
 ;;^UTILITY(U,$J,358.4,1138,0)
 ;;=URINARY SYMPTOMS^16^84
 ;;^UTILITY(U,$J,358.4,1139,0)
 ;;=AFTERCARE POST SURGERY^1^84
 ;;^UTILITY(U,$J,358.4,1140,0)
 ;;=SUICIDAL IDEATIONS/ATTEMPTS^13^84
 ;;^UTILITY(U,$J,358.4,1141,0)
 ;;=HOSPICE CARE SUPERVISION^2^85
 ;;^UTILITY(U,$J,358.4,1142,0)
 ;;=PROLONGED SERVICES^3^85
 ;;^UTILITY(U,$J,358.4,1143,0)
 ;;=ADVANCE CARE PLANNING^1^85
 ;;^UTILITY(U,$J,358.4,1144,0)
 ;;=TEAM CONFERENCE^4^85
 ;;^UTILITY(U,$J,358.4,1145,0)
 ;;=NEOPLASMS^9^86
 ;;^UTILITY(U,$J,358.4,1146,0)
 ;;=CARDIOVASCULAR DISORDERS^2^86
 ;;^UTILITY(U,$J,358.4,1147,0)
 ;;=MENTAL HEALTH^8^86
 ;;^UTILITY(U,$J,358.4,1148,0)
 ;;=NEUROLOGICAL CONDITIONS^10^86
 ;;^UTILITY(U,$J,358.4,1149,0)
 ;;=GI DISORDERS^5^86
 ;;^UTILITY(U,$J,358.4,1150,0)
 ;;=LIVER DISORDERS^7^86
 ;;^UTILITY(U,$J,358.4,1151,0)
 ;;=KIDNEY DISORDERS^6^86
 ;;^UTILITY(U,$J,358.4,1152,0)
 ;;=RESPIRATORY DISORDERS^11^86
 ;;^UTILITY(U,$J,358.4,1153,0)
 ;;=PALLIATIVE/HOSPICE ENCOUNTER^1^86
 ;;^UTILITY(U,$J,358.4,1154,0)
 ;;=OTHER CONDITIONS^13^86
 ;;^UTILITY(U,$J,358.4,1155,0)
 ;;=DEMENTIA^3^86
 ;;^UTILITY(U,$J,358.4,1156,0)
 ;;=GENERAL IM^4^86
 ;;^UTILITY(U,$J,358.4,1157,0)
 ;;=OTHER BACTERIAL DISEASES^12^86
 ;;^UTILITY(U,$J,358.4,1158,0)
 ;;=INPATIENT CONSULTATIONS^1^87
 ;;^UTILITY(U,$J,358.4,1159,0)
 ;;=INITIAL INPATIENT CARE^2^87
 ;;^UTILITY(U,$J,358.4,1160,0)
 ;;=SUBSEQUENT INPATIENT CARE^3^87
 ;;^UTILITY(U,$J,358.4,1161,0)
 ;;=DISCHARGE/PRONOUNCEMENT^4^87
 ;;^UTILITY(U,$J,358.4,1162,0)
 ;;=NH INITIAL INPATIENT CARE^5^87
 ;;^UTILITY(U,$J,358.4,1163,0)
 ;;=NH SUBSEQUENT INPATIENT CARE^6^87
 ;;^UTILITY(U,$J,358.4,1164,0)
 ;;=NH DISCHARGE/PRONOUNCEMENT^7^87
 ;;^UTILITY(U,$J,358.4,1165,0)
 ;;=HOSPICE CARE SUPERVISION^4^88
 ;;^UTILITY(U,$J,358.4,1166,0)
 ;;=ADVANCE LIFE PLANNING^2^88
 ;;^UTILITY(U,$J,358.4,1167,0)
 ;;=EDUCATION^3^88
 ;;^UTILITY(U,$J,358.4,1168,0)
 ;;=NON-VIDEO MONITORING^5^88
 ;;^UTILITY(U,$J,358.4,1169,0)
 ;;=TEAM CONFERENCE^7^88
 ;;^UTILITY(U,$J,358.4,1170,0)
 ;;=PROLONGED SERVICES^6^88
 ;;^UTILITY(U,$J,358.4,1171,0)
 ;;=ADVANCE CARE PLANNING^1^88
 ;;^UTILITY(U,$J,358.4,1172,0)
 ;;=NEW PATIENT ^2^89
 ;;^UTILITY(U,$J,358.4,1173,0)
 ;;=ESTABLISHED PATIENT ^1^89
 ;;^UTILITY(U,$J,358.4,1174,0)
 ;;=CONSULTATIONS ^3^89
 ;;^UTILITY(U,$J,358.4,1175,0)
 ;;=NEOPLASMS^9^90
 ;;^UTILITY(U,$J,358.4,1176,0)
 ;;=CARDIOVASCULAR DISORDERS^2^90
 ;;^UTILITY(U,$J,358.4,1177,0)
 ;;=MENTAL HEALTH^8^90
 ;;^UTILITY(U,$J,358.4,1178,0)
 ;;=NEUROLOGICAL CONDITIONS^10^90
 ;;^UTILITY(U,$J,358.4,1179,0)
 ;;=GI DISORDERS^5^90
 ;;^UTILITY(U,$J,358.4,1180,0)
 ;;=LIVER DISORDERS^7^90
 ;;^UTILITY(U,$J,358.4,1181,0)
 ;;=KIDNEY DISORDERS^6^90
 ;;^UTILITY(U,$J,358.4,1182,0)
 ;;=RESPIRATORY DISORDERS^11^90
 ;;^UTILITY(U,$J,358.4,1183,0)
 ;;=PALLIATIVE/HOSPICE ENCOUNTER^1^90
 ;;^UTILITY(U,$J,358.4,1184,0)
 ;;=OTHER CONDITIONS^13^90
 ;;^UTILITY(U,$J,358.4,1185,0)
 ;;=DEMENTIA^3^90
 ;;^UTILITY(U,$J,358.4,1186,0)
 ;;=GENERAL IM^4^90
 ;;^UTILITY(U,$J,358.4,1187,0)
 ;;=OTHER BACTERIAL DISEASES^12^90
 ;;^UTILITY(U,$J,358.4,1188,0)
 ;;=HEALTH/BEHAVIOR ASSESSMENT^1^91
 ;;^UTILITY(U,$J,358.4,1189,0)
 ;;=HEALTH/BEHAVIOR INTERVENTION^2^91
 ;;^UTILITY(U,$J,358.4,1190,0)
 ;;=PC COMMON DIAGNOSES^1^92
 ;;^UTILITY(U,$J,358.4,1191,0)
 ;;=ADMINISTRATIVE TOPICS^15^92
 ;;^UTILITY(U,$J,358.4,1192,0)
 ;;=ANGINA^16^92
 ;;^UTILITY(U,$J,358.4,1193,0)
 ;;=ATHEROSCLEROSIS^17^92
 ;;^UTILITY(U,$J,358.4,1194,0)
 ;;=CARDIOVASCULAR^18^92
 ;;^UTILITY(U,$J,358.4,1195,0)
 ;;=DERMATOLOGY^22^92
 ;;^UTILITY(U,$J,358.4,1196,0)
 ;;=EAR DISORDERS^24^92
 ;;^UTILITY(U,$J,358.4,1197,0)
 ;;=EENT^25^92
 ;;^UTILITY(U,$J,358.4,1198,0)
 ;;=ENDOCRINE/METABOLIC^26^92
 ;;^UTILITY(U,$J,358.4,1199,0)
 ;;=EYE DISORDERS^27^92
 ;;^UTILITY(U,$J,358.4,1200,0)
 ;;=EYE INJURY^28^92
 ;;^UTILITY(U,$J,358.4,1201,0)
 ;;=GASTROENTEROLOGY^29^92
 ;;^UTILITY(U,$J,358.4,1202,0)
 ;;=GU/RENAL^30^92
 ;;^UTILITY(U,$J,358.4,1203,0)
 ;;=HEADACHE^31^92
 ;;^UTILITY(U,$J,358.4,1204,0)
 ;;=HEART VALVE DISEASE^32^92
 ;;^UTILITY(U,$J,358.4,1205,0)
 ;;=HEMATOLOGY/ONCOLOGY^33^92
 ;;^UTILITY(U,$J,358.4,1206,0)
 ;;=HISTORY OF ILLNESS^34^92
 ;;^UTILITY(U,$J,358.4,1207,0)
 ;;=INFECTIOUS DISEASE^35^92
 ;;^UTILITY(U,$J,358.4,1208,0)
 ;;=LIVER DISEASE^36^92
 ;;^UTILITY(U,$J,358.4,1209,0)
 ;;=MENTAL HEALTH^38^92
 ;;^UTILITY(U,$J,358.4,1210,0)
 ;;=MOVEMENT DISORDERS^39^92
 ;;^UTILITY(U,$J,358.4,1211,0)
 ;;=MUSCULOSKELETAL^40^92
 ;;^UTILITY(U,$J,358.4,1212,0)
 ;;=NEUROLOGY^41^92
 ;;^UTILITY(U,$J,358.4,1213,0)
 ;;=PAIN^42^92
 ;;^UTILITY(U,$J,358.4,1214,0)
 ;;=PREVENTIVE HEALTH^43^92
 ;;^UTILITY(U,$J,358.4,1215,0)
 ;;=PULMONARY^44^92
 ;;^UTILITY(U,$J,358.4,1216,0)
 ;;=SEXUAL TRAUMA^45^92
 ;;^UTILITY(U,$J,358.4,1217,0)
 ;;=SIGNS,SYMPTOMS,CONDITIONS^46^92
 ;;^UTILITY(U,$J,358.4,1218,0)
 ;;=SPRAIN/STRAIN-INITIAL ENCOUNTER^47^92
 ;;^UTILITY(U,$J,358.4,1219,0)
 ;;=SUBSTANCE DISORDERS^48^92
 ;;^UTILITY(U,$J,358.4,1220,0)
 ;;=VARICOSE VEINS^50^92
 ;;^UTILITY(U,$J,358.4,1221,0)
 ;;=WOMEN'S HEALTH^51^92
 ;;^UTILITY(U,$J,358.4,1222,0)
 ;;=WOUNDS-INITIAL ENCOUNTER^52^92
 ;;^UTILITY(U,$J,358.4,1223,0)
 ;;=COMA^20^92
 ;;^UTILITY(U,$J,358.4,1224,0)
 ;;=CAUSES OF INJURY^19^92
 ;;^UTILITY(U,$J,358.4,1225,0)
 ;;=DEMENTIA^21^92
 ;;^UTILITY(U,$J,358.4,1226,0)
 ;;=LONG TERM CURRENT DRUG THERAPY^37^92
 ;;^UTILITY(U,$J,358.4,1227,0)
 ;;=ACQUIRED ABSENCE OF BODY PART(S)^2^92
 ;;^UTILITY(U,$J,358.4,1228,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^49^92
 ;;^UTILITY(U,$J,358.4,1229,0)
 ;;=ACSC ACUTE KIDNEY FAILURE^3^92
 ;;^UTILITY(U,$J,358.4,1230,0)
 ;;=ACSC ANGINA^4^92
 ;;^UTILITY(U,$J,358.4,1231,0)
 ;;=ACSC ASTHMA/BRONCHITIS/COPD^5^92
 ;;^UTILITY(U,$J,358.4,1232,0)
 ;;=ACSC CHF^6^92
 ;;^UTILITY(U,$J,358.4,1233,0)
 ;;=ACSC DEHYDRATION^7^92
 ;;^UTILITY(U,$J,358.4,1234,0)
 ;;=ACSC DIABETES TYPE 1^8^92
 ;;^UTILITY(U,$J,358.4,1235,0)
 ;;=ACSC DIABETES TYPE 2^9^92
 ;;^UTILITY(U,$J,358.4,1236,0)
 ;;=ACSC HYPERTENSION^10^92
 ;;^UTILITY(U,$J,358.4,1237,0)
 ;;=ACSC INFECTIOUS GASTROENTERITIS^11^92
 ;;^UTILITY(U,$J,358.4,1238,0)
 ;;=ACSC PNEUMONIA^12^92
 ;;^UTILITY(U,$J,358.4,1239,0)
 ;;=ACSC UTI^13^92
 ;;^UTILITY(U,$J,358.4,1240,0)
 ;;=ACSC VIRAL ENTERITIS^14^92
 ;;^UTILITY(U,$J,358.4,1241,0)
 ;;=E-CIG/VAPE LUNG INJURY^23^92
 ;;^UTILITY(U,$J,358.4,1242,0)
 ;;=CRITICAL CARE^2^93
 ;;^UTILITY(U,$J,358.4,1243,0)
 ;;=EMERGENCY DEPARTMENT^3^93
 ;;^UTILITY(U,$J,358.4,1244,0)
 ;;=INPT CONSULT-INITIAL^4^93
 ;;^UTILITY(U,$J,358.4,1245,0)
 ;;=INPT CONSULT-F/U^5^93
 ;;^UTILITY(U,$J,358.4,1246,0)
 ;;=MD/NP/PA EHR ASSESSMENT^1^93
 ;;^UTILITY(U,$J,358.4,1247,0)
 ;;=SEIZURES/EPILEPSY/SPELLS^7^94
 ;;^UTILITY(U,$J,358.4,1248,0)
 ;;=CEREBROVASCULAR DISEASE^2^94
 ;;^UTILITY(U,$J,358.4,1249,0)
 ;;=DIZZINESS^3^94
 ;;^UTILITY(U,$J,358.4,1250,0)
 ;;=ENCEPHALOPATHY^4^94
 ;;^UTILITY(U,$J,358.4,1251,0)
 ;;=HEADACHE^5^94
 ;;^UTILITY(U,$J,358.4,1252,0)
 ;;=OTHER^6^94
 ;;^UTILITY(U,$J,358.4,1253,0)
 ;;=CARDIAC DISORDERS^1^94
 ;;^UTILITY(U,$J,358.4,1254,0)
 ;;=SYMPTOMS^9^94
 ;;^UTILITY(U,$J,358.4,1255,0)
 ;;=VISION DISTURBANCES^10^94
 ;;^UTILITY(U,$J,358.4,1256,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^8^94
 ;;^UTILITY(U,$J,358.4,1257,0)
 ;;=COVID-19 CONFIRMED^2^96
 ;;^UTILITY(U,$J,358.4,1258,0)
 ;;=COVID-19 ACTUAL EXPOSURE^3^96
 ;;^UTILITY(U,$J,358.4,1259,0)
 ;;=COVID-19 POSSIBLE EXPOSURE^4^96
 ;;^UTILITY(U,$J,358.4,1260,0)
 ;;=COVID-19 RELATED COND/SYMP^5^96
 ;;^UTILITY(U,$J,358.4,1261,0)
 ;;=COVID-19 SCREEN^1^96
 ;;^UTILITY(U,$J,358.4,1262,0)
 ;;=ENVIRONMENTAL VISIT-EST PT^1^97
 ;;^UTILITY(U,$J,358.4,1263,0)
 ;;=ENVIRONMENTAL VISIT-NEW PT^2^97
 ;;^UTILITY(U,$J,358.4,1264,0)
 ;;=REGISTRY^1^98
